tirzepatide fda news - Search News

FDA keeps Mounjaro off shortage list

pulmonologyadvisor · 3h

FDA Says Shortage of GLP-1 Tirzepatide Is Over

The US FDA re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over.

GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide

Becker's Hospital Review · 4d

FDA reaffirms end of Mounjaro shortage

FDA resolves two-year shortage of Mounjaro and Zepbound after pushback from compounding pharmacies. Lawsuit filed, but agency reaffirms decision.

FDA keeps Mounjaro off shortage list after reevaluation

The Food and Drug Administration (FDA) has reaffirmed that Mounjaro and Zepbound are no longer in shortage following a reevaluation of its decision to remove it from federal drug shortage list

FDA, obstructive sleep apnea

emjreviews.com · 2h

Eli Lilly’s tirzepatide wins FDA nod for sleep apnea

Eli Lilly’s weight-loss drug tirzepatide has become the first drug for obstructive sleep apnea, a common but serious sleep disorder.

The Pharma Letter · 1h

FDA approves Lilly drug for obstructive sleep apnea

US pharma major Eli Lilly today announced the US Food and Drug Administration (FDA) approved Zepbound its (tirzepatide) as the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity.

KETV Omaha · 19h

FDA approves weight-loss drug Zepbound for obstructive sleep apnea

The FDA approval for sleep apnea is based on two company-sponsored ... Treatment with Zepbound, whose generic name is tirzepatide, led to improvements in both sets of patients, according to results published in June in the New England Journal of Medicine.

4don MSN

FDA says tirzepatide shortage is over after taking a second look

The FDA said Thursday it’s standing by its earlier decision that the shortage of tirzepatide — the active ingredient in Eli ...

3d

FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage

Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...

FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period

The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put ...

MedPage Today3d

FDA Says Compounded Tirzepatide Must Exit the Market

Approved in 2022 for type 2 diabetes and in 2023 for chronic weight management along with diet and exercise, tirzepatide is ...

FDA reaffirms decision to erase Eli Lilly's tirzepatide from shortage list, halting future flow of knockoffs

The FDA has doubled down on its decision to remove Eli Lilly’s tirzepatide from its list of products that are in shortage. | ...

3d

The FDA says the Zepbound shortage is over. That's rattling the weight loss industry

The U.S. Food and Drug Administration announced Thursday that the shortage of tirzepatide — the active ingredient in Eli ...

Is a contrarian leader good for the FDA?

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results